The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Induction treatment with FOLFOXIRI + bevacizumab (BV) followed by chemo-radiotherapy (CRT) + BV and surgery in locally advanced rectal carcinoma (LARC): The phase II TRUST trial.
 
Caterina Vivaldi
No Relationships to Disclose
 
Aldo Sainato
No Relationships to Disclose
 
Sara Lonardi
No Relationships to Disclose
 
Piero Buccianti
No Relationships to Disclose
 
Lorenzo Marcucci
No Relationships to Disclose
 
Francesco Di Clemente
No Relationships to Disclose
 
Gianna Musettini
No Relationships to Disclose
 
Sabrina Montrone
No Relationships to Disclose
 
Francesca Bergamo
No Relationships to Disclose
 
Matteo Franceschi
No Relationships to Disclose
 
Laura Ginocchi
No Relationships to Disclose
 
Angelo Martignetti
No Relationships to Disclose
 
Concetta Laliscia
No Relationships to Disclose
 
Francesca Battaglin
No Relationships to Disclose
 
Lucio Urbani
No Relationships to Disclose
 
Bruno Manfredi
No Relationships to Disclose
 
Laura Rumano'
No Relationships to Disclose
 
Francesco Sidoti
No Relationships to Disclose
 
Alfredo Falcone
Honoraria - Amgen; Bayer; Lilly; Merck Serono; Roche; Sanofi
Consulting or Advisory Role - Amgen; Bayer; Lilly; Merck Serono; Roche; Sanofi
Speakers' Bureau - Amgen; Bayer; Lilly; Merck Serono; Roche; Sanofi
Research Funding - Amgen; Bayer; Merck Serono; Roche; Sanofi
 
Gianluca Masi
Honoraria - Amgen; Merck Serono; Roche; Sirtex Medical